Inventor
GE SHENGXIANG
CN13 patents
⚠️ This page may combine multiple inventors who share the name “GE SHENGXIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV XIAMEN
6 patentsUS11339194B2May 24, 2022
Truncated rotavirus VP4 protein and application thereof
UNIV XIAMEN0 citations55
US10487301B2Nov 26, 2019
Reaction tube for nucleic acid amplification capable of controlling liquid circulation path
UNIV XIAMEN0 citations47
US10309964B2Jun 4, 2019
Method for assessing risk of human cytomegalovirus active infection in body and related kit
UNIV XIAMEN0 citations47
US9952217B2Apr 24, 2018
Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect
UNIV XIAMEN0 citations46
US10723767B2Jul 28, 2020
Truncated rotavirus VP4 protein and application thereof
UNIV XIAMEN0 citations45
US9862933B2Jan 9, 2018
Method for in-vitro preparation of double-layered virus-like particles of rotavirus
UNIV XIAMEN0 citations45
XIA NINGSHAO
3 patentsUS9428554B2Aug 30, 2016
Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
XIA NINGSHAO0 citations49
US8715695B2May 6, 2014
Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits
XIA NINGSHAO0 citations49
US8524868B2Sep 3, 2013
Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits
XIA NINGSHAO1 citations49
BEIJING WANTAI BIOLOG PHARMACY
2 patentsUS7786264B2Aug 31, 2010
Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof
BEIJING WANTAI BIOLOG PHARMACY4 citations60
US7615228B2Nov 10, 2009
Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits
BEIJING WANTAI BIOLOG PHARMACY3 citations60